Presynaptic dopaminergic activity of phencyclidine in rat caudate

Steven Johnson, P. E. Haroldsen, B. J. Hoffer, R. Freedman

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

This study tested the hypothesis that phencyclidine (PCP) is an indirect dopamine (DA) agonist in the caudate nucleus. Single caudate neurons in rats anesthetized with urethane were recorded extracellularly with multibarrel micropipettes. Effects of drug solutions, applied by pressure microejection, were measured as changes in spontaneous and evoked neuronal activity. Caudate neurons were classified according to their latency-to-discharge in response to supramaximal cortical stimulation. PCP inhibited the spontaneous activity of 92% of neurons with latencies <13 msec, while DA inhibited 87%. Both drugs inhibited evoked activity significantly less than spontaneous activity (P <.01). Neurons with latencies > 13 msec were excited by DA significantly more often (45%) than by PCP (13%; P <.05). Receptor stereospecificity is suggested by the finding that the (+)-isomer of the 3-methyl piperidine derivative of PCP was significantly more potent than the (-)-isomer for inhibition of spontaneous activity. Mg++, which blocks presynaptic release of neurotransmitter, significantly antagonized inhibitory effects of PCP on spontaneous activity, which suggests a presynaptic effect of PCP. DA, which acts postsynaptically, was much less affected by Mg++. The potency of PCP was significantly less in rats treated with reserpine or 6-hydroxydopamine than in control rats, suggesting the endogenous DA is required for the action of PCP. Fluphenazine and (+)-butaclamol, potent DA-receptor antagonists, blocked the effect of PCP, but (-)-butaclamol did not. These results support the hypothesis that PCP facilitates release and/or inhibits reuptake of DA in nerve terminals and thereby acts as an indirect DA agonist in the caudate. However, there may be a subpopulation of caudate neurons in which PCP acts by a nondopaminergic mechanism.

Original languageEnglish (US)
Pages (from-to)322-332
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume229
Issue number1
StatePublished - 1984
Externally publishedYes

Fingerprint

Phencyclidine
Dopamine
Butaclamol
Neurons
Dopamine Agonists
Fluphenazine
Dopamine Antagonists
Caudate Nucleus
Oxidopamine
Reserpine
Urethane
Neurotransmitter Agents
Pressure
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Presynaptic dopaminergic activity of phencyclidine in rat caudate. / Johnson, Steven; Haroldsen, P. E.; Hoffer, B. J.; Freedman, R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 229, No. 1, 1984, p. 322-332.

Research output: Contribution to journalArticle

Johnson, Steven ; Haroldsen, P. E. ; Hoffer, B. J. ; Freedman, R. / Presynaptic dopaminergic activity of phencyclidine in rat caudate. In: Journal of Pharmacology and Experimental Therapeutics. 1984 ; Vol. 229, No. 1. pp. 322-332.
@article{e7505645f79e4e62a0a43df965dfc8b2,
title = "Presynaptic dopaminergic activity of phencyclidine in rat caudate",
abstract = "This study tested the hypothesis that phencyclidine (PCP) is an indirect dopamine (DA) agonist in the caudate nucleus. Single caudate neurons in rats anesthetized with urethane were recorded extracellularly with multibarrel micropipettes. Effects of drug solutions, applied by pressure microejection, were measured as changes in spontaneous and evoked neuronal activity. Caudate neurons were classified according to their latency-to-discharge in response to supramaximal cortical stimulation. PCP inhibited the spontaneous activity of 92{\%} of neurons with latencies <13 msec, while DA inhibited 87{\%}. Both drugs inhibited evoked activity significantly less than spontaneous activity (P <.01). Neurons with latencies > 13 msec were excited by DA significantly more often (45{\%}) than by PCP (13{\%}; P <.05). Receptor stereospecificity is suggested by the finding that the (+)-isomer of the 3-methyl piperidine derivative of PCP was significantly more potent than the (-)-isomer for inhibition of spontaneous activity. Mg++, which blocks presynaptic release of neurotransmitter, significantly antagonized inhibitory effects of PCP on spontaneous activity, which suggests a presynaptic effect of PCP. DA, which acts postsynaptically, was much less affected by Mg++. The potency of PCP was significantly less in rats treated with reserpine or 6-hydroxydopamine than in control rats, suggesting the endogenous DA is required for the action of PCP. Fluphenazine and (+)-butaclamol, potent DA-receptor antagonists, blocked the effect of PCP, but (-)-butaclamol did not. These results support the hypothesis that PCP facilitates release and/or inhibits reuptake of DA in nerve terminals and thereby acts as an indirect DA agonist in the caudate. However, there may be a subpopulation of caudate neurons in which PCP acts by a nondopaminergic mechanism.",
author = "Steven Johnson and Haroldsen, {P. E.} and Hoffer, {B. J.} and R. Freedman",
year = "1984",
language = "English (US)",
volume = "229",
pages = "322--332",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Presynaptic dopaminergic activity of phencyclidine in rat caudate

AU - Johnson, Steven

AU - Haroldsen, P. E.

AU - Hoffer, B. J.

AU - Freedman, R.

PY - 1984

Y1 - 1984

N2 - This study tested the hypothesis that phencyclidine (PCP) is an indirect dopamine (DA) agonist in the caudate nucleus. Single caudate neurons in rats anesthetized with urethane were recorded extracellularly with multibarrel micropipettes. Effects of drug solutions, applied by pressure microejection, were measured as changes in spontaneous and evoked neuronal activity. Caudate neurons were classified according to their latency-to-discharge in response to supramaximal cortical stimulation. PCP inhibited the spontaneous activity of 92% of neurons with latencies <13 msec, while DA inhibited 87%. Both drugs inhibited evoked activity significantly less than spontaneous activity (P <.01). Neurons with latencies > 13 msec were excited by DA significantly more often (45%) than by PCP (13%; P <.05). Receptor stereospecificity is suggested by the finding that the (+)-isomer of the 3-methyl piperidine derivative of PCP was significantly more potent than the (-)-isomer for inhibition of spontaneous activity. Mg++, which blocks presynaptic release of neurotransmitter, significantly antagonized inhibitory effects of PCP on spontaneous activity, which suggests a presynaptic effect of PCP. DA, which acts postsynaptically, was much less affected by Mg++. The potency of PCP was significantly less in rats treated with reserpine or 6-hydroxydopamine than in control rats, suggesting the endogenous DA is required for the action of PCP. Fluphenazine and (+)-butaclamol, potent DA-receptor antagonists, blocked the effect of PCP, but (-)-butaclamol did not. These results support the hypothesis that PCP facilitates release and/or inhibits reuptake of DA in nerve terminals and thereby acts as an indirect DA agonist in the caudate. However, there may be a subpopulation of caudate neurons in which PCP acts by a nondopaminergic mechanism.

AB - This study tested the hypothesis that phencyclidine (PCP) is an indirect dopamine (DA) agonist in the caudate nucleus. Single caudate neurons in rats anesthetized with urethane were recorded extracellularly with multibarrel micropipettes. Effects of drug solutions, applied by pressure microejection, were measured as changes in spontaneous and evoked neuronal activity. Caudate neurons were classified according to their latency-to-discharge in response to supramaximal cortical stimulation. PCP inhibited the spontaneous activity of 92% of neurons with latencies <13 msec, while DA inhibited 87%. Both drugs inhibited evoked activity significantly less than spontaneous activity (P <.01). Neurons with latencies > 13 msec were excited by DA significantly more often (45%) than by PCP (13%; P <.05). Receptor stereospecificity is suggested by the finding that the (+)-isomer of the 3-methyl piperidine derivative of PCP was significantly more potent than the (-)-isomer for inhibition of spontaneous activity. Mg++, which blocks presynaptic release of neurotransmitter, significantly antagonized inhibitory effects of PCP on spontaneous activity, which suggests a presynaptic effect of PCP. DA, which acts postsynaptically, was much less affected by Mg++. The potency of PCP was significantly less in rats treated with reserpine or 6-hydroxydopamine than in control rats, suggesting the endogenous DA is required for the action of PCP. Fluphenazine and (+)-butaclamol, potent DA-receptor antagonists, blocked the effect of PCP, but (-)-butaclamol did not. These results support the hypothesis that PCP facilitates release and/or inhibits reuptake of DA in nerve terminals and thereby acts as an indirect DA agonist in the caudate. However, there may be a subpopulation of caudate neurons in which PCP acts by a nondopaminergic mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0021242742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021242742&partnerID=8YFLogxK

M3 - Article

C2 - 6707946

AN - SCOPUS:0021242742

VL - 229

SP - 322

EP - 332

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -